Oral iron supplementation with ferric maltol in patients with pulmonary hypertension

Karen M. Olsson, Jan Fuge, Torben Brod, Jan C. Kamp, Jan Schmitto, Tibor Kempf, Johann Bauersachs, Marius M. Hoeper

Source: Eur Respir J, 56 (5) 2000616; 10.1183/13993003.00616-2020
Journal Issue: November
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Karen M. Olsson, Jan Fuge, Torben Brod, Jan C. Kamp, Jan Schmitto, Tibor Kempf, Johann Bauersachs, Marius M. Hoeper. Oral iron supplementation with ferric maltol in patients with pulmonary hypertension. Eur Respir J, 56 (5) 2000616; 10.1183/13993003.00616-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Iron deficiency is common in idiopathic pulmonary arterial hypertension
Source: Eur Respir J 2011; 37: 1386-1391
Year: 2011



Effect of zinc supplementation in children with asthma
Source: Virtual Congress 2021 – Early-life infections, wheezing and asthma
Year: 2021


Iron carboxymaltose improves exercise tolerance and right heart strain in patients with PAH and iron deficiency: A long-term pilot study
Source: International Congress 2017 – New insights into pulmonary hypertension from recent trials
Year: 2017



High prevalence of iron deficiency in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2008 - Pulmonary hypertension I
Year: 2008

Acute effects of oxygen supplementation during exercise in patients with pulmonary arterial hypertension
Source: International Congress 2019 – Exercise physiopathology in various respiratory diseases
Year: 2019



Iron deficiency in idiopathic pulmonary arterial hypertension
Source: Annual Congress 2010 - Pulmonary hypertension
Year: 2010


Iron deficiency in patients with systemic sclerosis-associated pulmonary arterial hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012

Effect of zinc supplementation on respiratory infections in children with cystic fibrosis
Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection
Year: 2009


Effects of oxygen supplementation during pulmonary rehabilitation in COPD normoxemic patients
Source: Annual Congress 2010 - Rehabilitation: more than just exercise
Year: 2010

Efficacy of long-lasting magnesium supplementation in asthmatic children
Source: Annual Congress 2004 - New aspects of drug therapy in paediatric asthma
Year: 2004


The effect of oral zinc sulphate on immune system of patients with pulmonary tuberculosis
Source: Annual Congress 2008 - Miscellaneous respiratory infections
Year: 2008


Effects of oxygen supplementation during exercise on hemodynamic responses in patients with pulmonary arterial hypertension
Source: Virtual Congress 2020 – New insights into evaluation and treatment of respiratory disease
Year: 2020


Outcome of vitamin A & zinc supplementation in the treatment of smear positive pulmonary tuberculosis patients
Source: Annual Congress 2007 - Clinical tuberculosis
Year: 2007


Iron deficiency in non-anemic patients with chronic obstructive pulmonary disease
Source: Annual Congress 2011 - COPD: mechanisms and biomarker
Year: 2011


The acute and chronic effects of dietry nitrate on exercise tolerance in COPD patients
Source: International Congress 2015 – Functional capacity, exercise and pulmonary rehabilitation in chronic lung diseases
Year: 2015

Effect of suplementary dietary antioxidants in COPD patients
Source: Eur Respir J 2006; 28: Suppl. 50, 428s
Year: 2006

Efficacy of antioxidant supplementation diet in asthmatic children
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004

Oral L-arginine supplementation in cystic fibrosis patients: a placebo-controlled study
Source: Eur Respir J 2005; 25: 62-68
Year: 2005



BMPR2 mutations and iron metabolism in pulmonary arterial hypertension patients
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021


Co-application of oxygen improves iloprost inhalation in pulmonary hypertension patients with long-term oxygen therapy
Source: Eur Respir J 2001; 18: Suppl. 33, 324s
Year: 2001